Filtros : "FMRP" "Rossi, Marcos Antonio" "Blefari, Valdecir" Removido: "Oliveira, José Antonio Apparecido de" Limpar

Filtros



Refine with date range


  • Source: European Heart Journal: Acute Cardiovascular Care. Unidade: FMRP

    Subjects: CIRROSE HEPÁTICA, MICROCIRCULAÇÃO, INFARTO DO MIOCÁRDIO, HEMORRAGIA, VASOPRESSINAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CARMO, Lucas S. et al. Involvement of the microvasculature in the pathogenesis of terlipressin-related myocardial infarction. European Heart Journal: Acute Cardiovascular Care, 2014Tradução . . Disponível em: https://doi.org/10.1177/2048872614534921. Acesso em: 05 maio 2024.
    • APA

      Carmo, L. S., Baima, D. C., Blefari, V., Zonta, V., Troncon, L. E. de A., & Rossi, M. A. (2014). Involvement of the microvasculature in the pathogenesis of terlipressin-related myocardial infarction. European Heart Journal: Acute Cardiovascular Care. doi:10.1177/2048872614534921
    • NLM

      Carmo LS, Baima DC, Blefari V, Zonta V, Troncon LE de A, Rossi MA. Involvement of the microvasculature in the pathogenesis of terlipressin-related myocardial infarction [Internet]. European Heart Journal: Acute Cardiovascular Care. 2014 ;[citado 2024 maio 05 ] Available from: https://doi.org/10.1177/2048872614534921
    • Vancouver

      Carmo LS, Baima DC, Blefari V, Zonta V, Troncon LE de A, Rossi MA. Involvement of the microvasculature in the pathogenesis of terlipressin-related myocardial infarction [Internet]. European Heart Journal: Acute Cardiovascular Care. 2014 ;[citado 2024 maio 05 ] Available from: https://doi.org/10.1177/2048872614534921
  • Source: PLoS Neglected Tropical Diseases. Unidade: FMRP

    Assunto: DOENÇA DE CHAGAS

    Versão PublicadaHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ROSSI, Marcos Antonio et al. Coronary microvascular disease in chronic chagas cardiomyopathy including an overview on history, pathology, and other proposed pathogenic mechanisms. PLoS Neglected Tropical Diseases, v. 4, n. 8, p. e674-1 - e674-12, 2010Tradução . . Disponível em: https://repositorio.usp.br/directbitstream/8fe158b2-1dec-4db3-bfa3-ab898653b846/002178829.pdf. Acesso em: 05 maio 2024.
    • APA

      Rossi, M. A., Tanowitz, H. B., Malvestio, L. M., Celes, M. R., Campos, E. C., Blefari, V., & Prado, C. M. (2010). Coronary microvascular disease in chronic chagas cardiomyopathy including an overview on history, pathology, and other proposed pathogenic mechanisms. PLoS Neglected Tropical Diseases, 4( 8), e674-1 - e674-12. Recuperado de https://repositorio.usp.br/directbitstream/8fe158b2-1dec-4db3-bfa3-ab898653b846/002178829.pdf
    • NLM

      Rossi MA, Tanowitz HB, Malvestio LM, Celes MR, Campos EC, Blefari V, Prado CM. Coronary microvascular disease in chronic chagas cardiomyopathy including an overview on history, pathology, and other proposed pathogenic mechanisms [Internet]. PLoS Neglected Tropical Diseases. 2010 ; 4( 8): e674-1 - e674-12.[citado 2024 maio 05 ] Available from: https://repositorio.usp.br/directbitstream/8fe158b2-1dec-4db3-bfa3-ab898653b846/002178829.pdf
    • Vancouver

      Rossi MA, Tanowitz HB, Malvestio LM, Celes MR, Campos EC, Blefari V, Prado CM. Coronary microvascular disease in chronic chagas cardiomyopathy including an overview on history, pathology, and other proposed pathogenic mechanisms [Internet]. PLoS Neglected Tropical Diseases. 2010 ; 4( 8): e674-1 - e674-12.[citado 2024 maio 05 ] Available from: https://repositorio.usp.br/directbitstream/8fe158b2-1dec-4db3-bfa3-ab898653b846/002178829.pdf
  • Source: Laboratory Investigation. Unidade: FMRP

    Subjects: SARCOLEMA, SEPSE, MIOCARDIOPATIAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CELES, Mara Rúbia Nunes et al. Disruption of sarcolemmal dystrophin and 'beta'-dystroglycan may be a potential mechanism for myocardial dysfunction in severe sepsis. Laboratory Investigation, v. 90, n. 4, p. 531-542, 2010Tradução . . Disponível em: https://doi.org/10.1186/cc9157. Acesso em: 05 maio 2024.
    • APA

      Celes, M. R. N., Malvestio, L. M., Torres-Dueñas, D., Blefari, V., Campos, É. C., Ramos, S. G., et al. (2010). Disruption of sarcolemmal dystrophin and 'beta'-dystroglycan may be a potential mechanism for myocardial dysfunction in severe sepsis. Laboratory Investigation, 90( 4), 531-542. doi:10.1186/cc9157
    • NLM

      Celes MRN, Malvestio LM, Torres-Dueñas D, Blefari V, Campos ÉC, Ramos SG, Prado CM, Cunha F de Q, Rossi MA. Disruption of sarcolemmal dystrophin and 'beta'-dystroglycan may be a potential mechanism for myocardial dysfunction in severe sepsis [Internet]. Laboratory Investigation. 2010 ; 90( 4): 531-542.[citado 2024 maio 05 ] Available from: https://doi.org/10.1186/cc9157
    • Vancouver

      Celes MRN, Malvestio LM, Torres-Dueñas D, Blefari V, Campos ÉC, Ramos SG, Prado CM, Cunha F de Q, Rossi MA. Disruption of sarcolemmal dystrophin and 'beta'-dystroglycan may be a potential mechanism for myocardial dysfunction in severe sepsis [Internet]. Laboratory Investigation. 2010 ; 90( 4): 531-542.[citado 2024 maio 05 ] Available from: https://doi.org/10.1186/cc9157

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024